Skip to content

13F-HR filed by Column Group LLC

Column Group LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-07-24, with 7 holding rows worth $257,666,921.

Accession
0000950123-23-006249
Filed
2023-07-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 7 entries on the cover page, a total value of $257,666,921 stated on the cover page (in dollars after the unit check, H1), rows summing to $257,666,921 with VALUE read as dollars as filed, 13F file number 028-20797. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock2,577,220$68,940,635dollars as filed
TENAYA THERAPEUTICS INC87990A106COM9,400,290$55,179,702dollars as filed
RAPT THERAPEUTICS INC75382E109COM2,680,621$50,127,613dollars as filed
NGM BIOPHARMACEUTICALS INC62921N105COM18,136,735$46,974,144dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM3,568,181$27,689,085dollars as filed
Surrozen, Inc.86889P109COM9,414,795$5,178,137dollars as filed
EFFECTOR THERAPEUTICS INC28202V108COM4,309,329$3,577,605dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-006249this filing2023-07-24acceptance time not in the bulk data set